Effectiveness and safety of safinamide in routine clinical practice in a Belgian Parkinson’s disease population: an open-label, levodopa add-on study

por Bergmans, Bruno, Bourgeois, Philip, Cras, Patrick, Dethy, Sophie, De Klippel, Nina, Franco, Gianni, Garraux, Gaëtan, Geens, Karine, Jacquerye, Philippe, Jeanjean, Anne, Supiot, Frédéric, Van der Linden, Chris, Krygier, Claude
Publicado 2022

Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review

por Volkmann, Jens, Albanese, Alberto, Antonini, Angelo, Chaudhuri, K. Ray, Clarke, Carl E., de Bie, Rob M. A., Deuschl, Günther, Eggert, Karla, Houeto, Jean-Luc, Kulisevsky, Jaime, Nyholm, Dag, Odin, Per, Østergaard, Karen, Poewe, Werner, Pollak, Pierre, Rabey, Jose Martin, Rascol, Olivier, Ruzicka, Evzen, Samuel, Michael, Speelman, Hans, Sydow, Olof, Valldeoriola, Francesc, van der Linden, Chris, Oertel, Wolfgang
Publicado 2013